| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.073 | 0.2 |